FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Sep 23, 2019
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on September 23, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 261382e7-e45c-4e25-88cf-eca7e0ebcfb3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1102521
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2025 | Not classified | Baltimore District Office | |
| March 30, 2017 | Not classified | Baltimore District Office |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1265326 - 2025-03-14
- FDA Inspection 1009830 - 2017-03-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.